Matinas biopharma to webcast conference call to discuss first quarter 2023 financial results and provide a business update on may 10, 2023

Bedminster, n.j., may 03, 2023 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announces that it will report first quarter 2023 financial results after market close on wednesday, may 10, 2023. matinas management will host an investment community conference call and webcast to discuss financial results and provide a business update at 4:30 p.m. eastern time (1:30 p.m. pacific time).
MTNB Ratings Summary
MTNB Quant Ranking